It was reported that the COX2 mutation is undetected in the early stage of CRC, whereas in large colon adenocarcinoma, the incidence of COX2 mutation is around 80%, indicating that the COX2 mutation is pivotal in the late stage of CRC [36]. This evidence concerns the gene PTGS2 and colon adenocarcinoma.